Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Editorial · 24 Sep 2015 Commentary · 26 Nov 2025 Evolving Cervical Cancer Prevention: Progress and Challenges
Recent advancements show HPV screening and co-testing reduce cervical cancer incidence more effectively than cytology. HPV self-sampling and AI-driven digital cytology improve accessibility and accuracy, especially
Conference abstract · 24 Oct 2016 The accuracy of p16/Ki-67 dual immunocytochemical staining in detecting high grade lesions in cervical smears with low grade abnormalities: Our experience from a pilot study
means of triaging cervical smears with low grade squamous abnormalities or as part of co-testing with cytology. While HPV testing has a high sensitivity, it has a low specificity ... LSIL if it were used as a triage…
Research article · 28 Sep 2021 The High-risk Human Papilloma Virus (Hr-HPV) in Abnormal Pap Smears
liquid-based cytology (LBC) and evaluated according to the Bethesda system. HPV-DNA co-testing was done using the Anyplex-II. Collected data were statistically analyzed to detect types ... HSIL compared to ASCUS. This…
Opinion · 26 Nov 2025 Evolving Cervical Cancer Screening: HPV, Tech, Equity
income regions. Addressing these through cost-effective strategies, targeted interventions, and improved modalities like co-testing is crucial for equitable global cervical cancer prevention
Article · 1 Aug 2022 Updated Annual Gynecologic Exam for the 21st Century
researchers reestablished the intervals for Pap test screening with the addition of human papillomavirus co-testing to identify cervical cancer risk and questioned the relevance of the annual breast
Review article · 30 Mar 2022 Knowledge and Beliefs about Cervical Cancer Screening among Insured Women Living in the US-Mexico Border City of El Paso
smear) alone every 3 years or hrHPV testing alone every 5 years or Co-testing (hrHPV+cervical cytology) every 5 years. These recommendations were the product of a manner
Conference abstract · 17 Oct 2016 Primary HPV genotyping with reflex Pap cytology for cervical cancer screening
safe as Pap cytology alone and as efficient for detecting CCA/ precursors as co-testing with Pap/HPV. Switching core screening technology from morphology-based Pap cytology to molecular

